SCHEMBL14770632

SCHEMBL14770632

c1cc(-c2ccc3oc4ccc(-n5c6ccccc6c6ccccc65)cc4c3c2)nc(-c2cc(-n3c4ccccc4c4ccccc43)ccn2)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRF P10586 3/20 0.33
PTPN2 P17706 3/20 0.33
PTPN1 P18031 3/20 0.33
MAPT P10636 3/20 0.33
KMT2A Q03164 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
PPP1CA P62136 1/20 0.33
NPY5R Q15761 1/20 0.31
KDM4E B2RXH2 3/20 0.31
HTT P42858 3/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
ALPL P05186 1/20 0.31
HSP90AA1 P07900 1/20 0.31
ALPI P09923 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14770703 0.91 KDM4E (0.36) PTPRFPTPN2PTPN1MAPTKMT2A
SCHEMBL10041340 0.91 KDM4E (0.38) PTPRFPTPN2PTPN1MAPTKMT2A
SCHEMBL14770639 0.89 KDM4E (0.34) PTPRFPTPN2PTPN1MAPTKMT2A
SCHEMBL14770569 0.88 KDM4E (0.38) PTPRFPTPN2PTPN1MAPTKMT2A
SCHEMBL14770629 0.87 KDM4E (0.38) PTPRFPTPN2PTPN1MAPTKMT2A
SCHEMBL14770637 0.86 PTPRF (0.34) PTPRFPTPN2PTPN1KDM4EL3MBTL1
SCHEMBL14770574 0.85 KDM4E (0.43) PTPRFPTPN2PTPN1KMT2AKDM4E
SCHEMBL14867943 0.85 KMT2A (0.38) PTPRFPTPN2PTPN1MAPTKMT2A
SCHEMBL10041344 0.85 KDM4E (0.35) PTPRFPTPN2PTPN1MAPTKMT2A
SCHEMBL20960179 0.84 PTPN1 (0.37) PTPRFPTPN2PTPN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L PTPRF 4476/4885PTPN2 2467/4885PTPN1 3409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.